Company Snapshot


Change Company Name
 
Glaxosmithkline Pharmaceuticals Ltd
Pharmaceuticals - Multinational
BSE Code
500660
NSE Symbol
GLAXO
P/E
49.58
ISIN Demat
INE159A01016
Div & Yield %
2.15
EPS
53.59
Book Value
132.30
Market Cap (Rs Cr.)
45,014.57
Face Value
10
Stock Price Details
Last Price (₹) 2,680.00
Change -12.65 (-0.48%)
Best Buy (₹) 0
Best Sell (₹) 0
Today's Range 2,611.60 - 2,680.00
52-Week Range 2,088.00 - 2,935.85
Beta (1 Year) 0.46
Chart
1 Day | 5 Day | 3 Month | 1 Year | 5 Year
Index Details
BSE 500, BSE 200, BSE HC, BSE DOLLEX, BSE Midcap
Corporate Announcements
GlaxoSmithKline Pharmaceuticals to table results
Volumes soar at Glaxosmithkline Pharmaceuticals Ltd counter
GSK Pharma gains as Q4 PAT rises 6% YoY to Rs 275 cr
GlaxoSmithKline Pharmaceuticals to hold AGM
Board of GlaxoSmithKline Pharmaceuticals recommends Final Dividend
Glaxosmithkline Pharmaceuticals consolidated net profit rises 5.70% in the March 2026 quarter
GSK Pharma Q4 PAT rises 6% YoY to Rs 275 cr
GlaxoSmithKline Pharmaceuticals to announce Quarterly Result
Glaxosmithkline appoints Vinay Subramanian as Commercial Head – Oncology
Glaxosmithkline Pharmaceuticals consolidated net profit rises 28.60% in the December 2025 quarter
Corporate Details
Incorporation Year : 1924
Chairman : Renu S. Karnad
Ownership Group : MNC Asc-Glaxo
Sector : Pharmaceuticals
Industry : Pharmaceuticals - Multinational
Registered Office :

Glaxosmithkline Pharmaceuticals Ltd
GSK House,
Dr Annie Besant Road Worli,
Mumbai,
Maharashtra - 400030,
Phone : 91-022-24959595,
Fax : 91-022-24959494
E-Mail : askus@gsk.com; ajay.a.nadkarni@gsk.com
URL : http://www.gsk-india.com
Investor Returns
Period Date Price(₹) Returns (%)
1Week 27-Jul-2026 2,550.20 +4.20
1Month 03-Jul-2026 2,392.75 +11.05
3Month 04-May-2026 2,351.10 +13.02
6Month 03-Feb-2026 2,435.15 +9.12
1Year 04-Aug-2025 2,865.25 -7.26
Mutual Funds Holding
Scheme Name % Holding Market Value (₹.Cr)
SBI Midcap Fund 1.22 294.04
Kotak Large & Midcap Fund 0.86 269.53
Nippon India Pharma Fund 2.47 223.77
Nippon India Growth Mid Cap .. 0.28 136.97
SBI Dividend Yield Fund 1.30 110.26
Peer Groups : Pharmaceuticals - Multinational
Company Last Price(₹) Change(%) 52Week High(₹) 52Week Low(₹) Market Cap(₹)
Abbott India Ltd 27,830.00 -0.13 34,220.00 25,164.00 59,215.89
Pfizer Ltd 4,850.00 -1.33 5,878.55 4,361.00 22,487.07
Astrazeneca Pharma India Ltd 8,161.95 -1.62 9,850.00 7,630.00 20,740.00
Procter & Gamble Health Ltd 6,463.50 -0.42 6,955.00 4,699.70 10,773.99
Sanofi Consumer Healthcare India Ltd 4,532.85 -0.08 5,493.10 3,950.50 10,447.61

Mail Us

Exclusive E-mail Id for redressal of investor grievances

jyotiinvestorgrievance@rediffmail.com
ATTENTION INVESTORS:
"Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day.      |      " KYC is one time excercise while dealing in securities markets-once KYC is done through a SEBI registered intermediary (broker,DP,Mutual Fund etc),you need not undergo the same process again when you approach another intermediary."      |      "Contents which are exclusively for Non-Broking Products/Services, Mutual Fund, Mutual Fund-SIP, Research reports, Insurance, etc. where the Member is just a distributor. These are not Exchange traded product and the Member is just acting as distributor. It should also state that all disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism."      |      “The Stock Exchange, Mumbai is not in any manner answerable, responsible or liable to any person or persons for any acts of omission or commission, errors, mistakes and/or violation, actual or perceived, by us or our partners, agents, associates etc., of any of the Rules, Regulations, Bye-laws of the Stock Exchange, Mumbai, SEBI Act or any other laws in force from time to time. The Stock Exchange, Mumbai is not answerable, responsible or liable for any information on this Website or for any services rendered by our employees, our servants, and us. ”      |      "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account." .......... Issued in the interest of investors"
Company Name Logo

Address

B- 78, 3rd Floor, Defence Colony
New Delhi – 110 024

RISK DISCLOSURES ON DERIVATIVES

Attention Investors

  • Stock Brokers can accept securities as margin only by pledge.
  • Update your mobile number & email Id with your Stock Broker/Depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.
  • Pay 20% upfront margin of the transaction value to trade in cash market segment.
  • Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.
  • Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month

Precautions for clients dealing in Options

  • Do not Share your trading credentials – login id & passwords including OTP’s.
  • Do not Trade in leveraged products like options without proper understanding, which could lead to losses.
  • Do not Write/ sell options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Do not Deals in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, calls, etc.
  • Do not Trade in “Options” based on recommendations from unauthorised / unregistered investment advisors and influencers.

NSE SEBI CM INZ000017939 | NSE SEBI F&O INZ000017939 | BSE SEBI CM INZ000017939 | NSDL : IN-DP-443-2019 | CDSL: IN-DP-443-2019 | NCDEX SEBI INZ000017939 | MCX SEBI INZ000017939

@2023 Jyoti Broking Pvt. Ltd. All rights reserved

Designed, developed and powered by CMOTS Infotech (ISO 9001:2015 certified)